Literature DB >> 9679551

ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2.

D Keppler1, I Leier, G Jedlitschky, J König.   

Abstract

The membrane proteins mediating the ATP-dependent transport of glutathione S-conjugates and related amphiphilic anions have been identified as the multidrug resistance proteins MRP1 and MRP2. These 190-kDa membrane glycoproteins were cloned in recent years and shown to be unidirectional, ATP-driven, export pumps with an amino acid identity of 49% in humans. MRP1 is detected in the plasma membrane of many cell types, including erythrocytes; whereas MRP2, also termed canalicular MRP (cMRP) or canalicular multispecific organic anion transporter (cMOAT), has been localized to the apical domain of polarized epithelia, such as the hepatocyte canalicular membrane and kidney proximal tubule luminal membrane. Physiologically important substrates of both transporters include glutathione S-conjugates, such as leukotriene C4, as well as bilirubin glucuronides. 17 beta-glucuronosyl estradiol and glutathione disulfide. Both transporters have been associated with multiple drug resistance of malignant tumors because of their capacity to pump drug conjugates and drug complexes across the plasma membrane into the extracellular space. The substrate specificity of MRP1 and MRP2 studied in inside-out oriented membrane vesicles is very different from MDR1 P-glycoprotein. MRP1 and MRP2 may be termed conjugate transporting ATPases, functioning in detoxification and, because of their role in glutathione disulfide export, in the defense against oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679551     DOI: 10.1016/s0009-2797(97)00158-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

Review 1.  Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Authors:  Rudolfs K Zalups; Christy C Bridges
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

3.  Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.

Authors:  R Xie; M R Bouw; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 4.  Molecular and ionic mimicry and the transport of toxic metals.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

5.  Multidrug resistance protein 1 (MRP1) in rabbit conjunctival epithelial cells: its effect on drug efflux and its regulation by adenoviral infection.

Authors:  Johnny J Yang; David K Ann; Ram Kannan; Vincent H L Lee
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

6.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

Authors:  J Wijnholds; E C deLange; G L Scheffer; D J van den Berg; C A Mol; M van der Valk; A H Schinkel; R J Scheper; D D Breimer; P Borst
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

7.  Molecular analysis and heavy metal detoxification of ABCC1/MRP1 in zebrafish.

Authors:  Yong Long; Qing Li; Zongbin Cui
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

8.  Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy.

Authors:  Lauren M Aleksunes; Ronnie L Yeager; Xia Wen; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

9.  Expression of chemoresistance-related genes and heat shock protein 72 in hyperthermic isolated limb perfusion of malignant melanoma: an experimental study.

Authors:  C Knorr; J O Pelz; J Göhl; W Hohenberger; T Meyer
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

10.  Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.

Authors:  Gabriele Buda; Deborah Ricci; C Chris Huang; Reyna Favis; Nadine Cohen; Sen H Zhuang; Jean-Luc Harousseau; Pieter Sonneveld; Joan Bladé; Robert Z Orlowski
Journal:  Ann Hematol       Date:  2010-06-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.